Skip to main content
Clinical Trials/NL-OMON43537
NL-OMON43537
Withdrawn
Phase 3

Improving quality of survivorship for breast cancer-related lymphedema by lymphatic microsurgery: A randomized controlled trial - BCRL-LVA study

Medisch Universitair Ziekenhuis Maastricht0 sites60 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Breast cancer-related lymphedema (BCRL)
Sponsor
Medisch Universitair Ziekenhuis Maastricht
Enrollment
60
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Eligibility Criteria

Inclusion Criteria

  • \- Woman over 18 years old
  • \- Treated for early stage breast cancer and underwent an SLNB, ALND or axillary radiotherapy
  • \- Early stage lymphedema of the arm (stage 1 \-\- 2b on ISL classification) with viable lymphatic vessels as determined by nearly infrared imaging
  • \- Excess limb volume \>\=10%
  • \- Followed three months conservative therapy (standard of care) according to best available care, this will be judged by skin therapists in our region
  • \- Primary breast cancer
  • \- Unilateral disease / treatment

Exclusion Criteria

  • \- Male sex
  • \- Stage 3 lymphedema of the arm with evident fat deposition and/or fibrosis
  • \- History of earlier lymph reconstruction efforts
  • \- Recurrent breast cancer
  • \- Distant breast cancer metastases
  • \- Bilateral disease / treatment
  • \- Medical history of cancer
  • \- Primary congenital lymphedema
  • \- Non\-viable lymphatic system as determined by lymphoscintigraphy at inclusion

Outcomes

Primary Outcomes

Not specified

Similar Trials